Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zaoren Anshen capsule combined with zolpidem for insomnia
ChiCTR-IPR-16009669Phase 4Not yet recruiting
- Sponsor
- Zhejiang Hospital of Traditional Chinese Medicine
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of zaoren anshen and zolpidem in Insomnia (4 arms), sponsored by Zhejiang Hospital of Traditional Chinese Medicine. Primary endpoints: Reduction rate of the insomnia severity index, Reduction rate of Pittsburgh Sleep Quality Index (PSQI) and 3 more. Planned start Nov 2016; status: not yet recruiting.
02
Drugs
zaoren anshenzolpidem
03
Conditions
Insomnia
Beyond the preview
Go deeper on ChiCTR-IPR-16009669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16009669.